1. Home
  2. LQDA vs NNE Comparison

LQDA vs NNE Comparison

Compare LQDA & NNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LQDA
  • NNE
  • Stock Information
  • Founded
  • LQDA 2004
  • NNE 2022
  • Country
  • LQDA United States
  • NNE United States
  • Employees
  • LQDA N/A
  • NNE N/A
  • Industry
  • LQDA Biotechnology: Pharmaceutical Preparations
  • NNE
  • Sector
  • LQDA Health Care
  • NNE
  • Exchange
  • LQDA Nasdaq
  • NNE NYSE
  • Market Cap
  • LQDA 1.3B
  • NNE 1.2B
  • IPO Year
  • LQDA 2018
  • NNE 2024
  • Fundamental
  • Price
  • LQDA $14.03
  • NNE $28.32
  • Analyst Decision
  • LQDA Strong Buy
  • NNE Strong Buy
  • Analyst Count
  • LQDA 7
  • NNE 2
  • Target Price
  • LQDA $26.67
  • NNE $58.00
  • AVG Volume (30 Days)
  • LQDA 886.3K
  • NNE 3.0M
  • Earning Date
  • LQDA 05-12-2025
  • NNE 02-13-2025
  • Dividend Yield
  • LQDA N/A
  • NNE N/A
  • EPS Growth
  • LQDA N/A
  • NNE N/A
  • EPS
  • LQDA N/A
  • NNE N/A
  • Revenue
  • LQDA $15,610,000.00
  • NNE N/A
  • Revenue This Year
  • LQDA N/A
  • NNE N/A
  • Revenue Next Year
  • LQDA $208.28
  • NNE $272.38
  • P/E Ratio
  • LQDA N/A
  • NNE N/A
  • Revenue Growth
  • LQDA N/A
  • NNE N/A
  • 52 Week Low
  • LQDA $8.26
  • NNE $3.25
  • 52 Week High
  • LQDA $16.99
  • NNE $48.05
  • Technical
  • Relative Strength Index (RSI)
  • LQDA 40.61
  • NNE N/A
  • Support Level
  • LQDA $13.50
  • NNE N/A
  • Resistance Level
  • LQDA $14.61
  • NNE N/A
  • Average True Range (ATR)
  • LQDA 0.71
  • NNE 0.00
  • MACD
  • LQDA -0.27
  • NNE 0.00
  • Stochastic Oscillator
  • LQDA 19.70
  • NNE 0.00

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

About NNE NANO NUCLEAR ENERGY INC

Nano Nuclear Energy Inc is an early-stage nuclear energy company developing smaller, cheaper, and safer portable clean energy solutions. It is focused on four business lines as part of development-Micro Nuclear Reactor Business is developing the next-generation nuclear microreactors, in particular ZEUS, a solid core battery reactor, and ODIN, a low-pressure salt coolant reactor; Fuel Processing Business; Fuel Fabrication Business; Fuel Transportation Business, and Nuclear Consultation Services.

Share on Social Networks: